Pricing Log in Create free account

NanoViricides, Inc. (NNVC) vs Promis Neurosciences (PMN)

NanoViricides, Inc. and Promis Neurosciences are both Biotechnology companies. NanoViricides, Inc. and Promis Neurosciences are of similar size ($32.9M and $32.7M). Across the 9 metrics below, NanoViricides, Inc. leads on 5 and Promis Neurosciences on 4.

Valuation

Metric NNVC PMN Biotechnology median
P/E n/m n/m 10.60
P/S n/m 16,913.44 9.40
P/B 3.09 0.75 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.28 0.66
EV/Sales n/m (5,572.97) 9.02
Earnings yield (30.08%) (324.53%) (32.88%)
Free cash flow yield (28.98%) (113.16%) (23.13%)

Profitability

Metric NNVC PMN Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (101.46%) (172.30%) (51.96%)
Return on assets (87.91%) (127.57%) (46.06%)
Return on invested capital (88.16%) 0.00% 0.00%

Growth

Metric NNVC PMN Biotechnology median
Revenue growth (TTM) — 450.00% 6.76%
EPS growth (last fiscal year) 34.92% (922.18%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NNVC PMN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.66 7.85 4.97
Net debt to EBITDA 0.36 0.15 1.01

Dividend

Metric NNVC PMN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NNVC PMN Biotechnology median
Market cap 32.92m 32.74m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack